Skip to main content

Advertisement

SpringerLink
Log in

Estimation of premium cost for HIV/AIDS patients under ART

  • Original Article
  • Published:
International Journal of System Assurance Engineering and Management Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The primary aim of this paper is to bring an insurance plan for HIV/AIDS patients. Recent studies based on antiretroviral therapy (ART) and highly active antiretroviral therapy (HAART) suggests long term survival of HIV/AIDS patients. Use of cure fraction model has revealed that a considerable proportion of patients are long term survivors out of the diseased cohort (Grover et al. 2019). The survival time is defined under the purview of CD4 cell counts which are considered to be the disease marker for HIV/AIDS patients. Many patients suffer financially along with risk of death. Here, we introduce an insurance plan which involves low risk for insurers and affordable premium for patients. The premium is calculated, using the survival estimates from Kaplan–Meier survival curve, on the basis of a deterministic model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Amatya R, Vajpayee M, Kaushik S, Kanswal S, Pandey RM, Seth P (2004) Lymphocyte immunophenotype reference ranges in healthy Indian adults: implications for management of HIV/AIDS in India. Clin Immunol 112(3):290–295

    Article  Google Scholar 

  • Badri M, Maartens G, Wood R (2001) Predictors and prognostic value of oral hairy leukoplakia and oral candidiasis in South African HIV-infected patients. SADJ 56(12):592–596.

  • Bowers NL, Gerber HU, Hickman JC, Jones DA, Nesbitt CJ (1986) Actuarial mathematics. Society of Actuaries, Itasca

    MATH  Google Scholar 

  • Chiang CL (1968) Introduction to stochastic processes in biostatistics. Wiley, New York

    MATH  Google Scholar 

  • Grover G, Vinit PK, Thakur AK (2018) Actuarial modeling of insurance premium for patients with acute lymphoblastic leukemia (ALL). J Appl Quan Methods 13(5):1842–4562

    Google Scholar 

  • Grover G, Thakur AK, Garg B (2019) Cure fraction estimation for traumatic lumbar puncture in patients with acute lymphoblastic leukemia. Res Rev J Oncol Hematol 7(3):12–21

    Google Scholar 

  • Haberman S, Pitacco E (2018) Actuarial models for disability insurance. Routledge.

  • Luptáková ID, Bilíková M (2014) Actuarial modeling of life insurance using decrement models. J Appl Math Stat Informatics 10(1):81–91

    Article  MathSciNet  Google Scholar 

  • Macdonald AS (1996) An actuarial survey of statistical models for decrement and transition data-I: multiple state, Poisson and Binomial models. Br Actuarial J 2(1):129–155

    Article  Google Scholar 

  • Norberg R (2002) Basic life insurance mathematics. Lecture notes, Laboratory of Actuarial Mathematics, University of Copenhagen.

  • Rejda GE (2011) Principles of risk management and insurance. Pearson Education India, Chennai.

  • Solomon S, Solomon SS, Ganesh AK (2006) AIDS in India. Postgrad Med J 82(971):545–547. https://doi.org/10.1136/pgmj.2006.044966

    Article  Google Scholar 

  • Slud EV (2012) Actuarial mathematics and life-table statistics. Chapman & Hall/CRC, New York.

  • Syndrome AID (1990) Interim proposal for a WHO staging system for HIV infection and disease. Weekly Epidemiol Rec 65:221–224

    Google Scholar 

  • Vajpayee M, Kaushik S, Sreenivas V, Wig N, Seth P (2005) CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1-infected Indian population: treatment implications. Clin Exp Immunol 141(3):485–490. https://doi.org/10.1111/j.1365-2249.2005.02857.x

    Article  Google Scholar 

  • Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, Mooney MD, Fraser MS, Sligar A, Larson HJ, Friedman J, Brown A, Dandona L, Fullman N, Haagsma J, Khalil I, Lim SS, Coates MM (2016) Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. Lancet HIV 3(8):e361–e387

    Article  Google Scholar 

  • World Health Organization (2005) Interim WHO clinical staging of HVI/AIDS and HIV/AIDS case definitions for surveillance: African Region (No. WHO/HIV/2005.02). World Health Organization, Geneva.

Download references

Author information

Authors and Affiliations

  1. Department of Statistics, University of Delhi, Delhi, 110007, India

    Gurprit Grover, *Parmeet Kumar Vinit & V. K. Sehgal

  2. Bundelkhand University, Jhansi, 284128, India

    Gurprit Grover, *Parmeet Kumar Vinit & V. K. Sehgal

Authors
  1. Gurprit Grover
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. *Parmeet Kumar Vinit
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. K. Sehgal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to *Parmeet Kumar Vinit.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grover, G., Vinit, *.K. & Sehgal, V.K. Estimation of premium cost for HIV/AIDS patients under ART. Int J Syst Assur Eng Manag 12, 77–83 (2021). https://doi.org/10.1007/s13198-020-01034-2

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13198-020-01034-2

Keywords

Search

Navigation